Search Results for "Career Progression"

Tom Caravela

Where Did My Interview Go Wrong?

Apr 24^th • 1 min read

Tom Caravela

Mastering the First Impression

Jan 29^th • 2 mins read

Tom Caravela

Interview Differentiator-Be a Story Teller

Mar 22^nd • 1 min read

Tom Caravela

12 Interview Techniques to Help Land Your Next Job

May 12^th • 1 min read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Retention – What Matters Most

Mar 15^th • 2 mins read

Tom Caravela

10 Ways to Make an Impact on a Phone Interview

Apr 9^th • 1 min read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

Tom Caravela

What to do When a Job Offer is Rescinded

Jul 20^th • 5 mins read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23^rd • 8 mins read

Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22^nd • 10 mins read

Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11^th • 4 mins read

Xuanyi Li, Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad, Seema Nagpal, Ronald S. Go, Kristin Wuichet, Eddy J. Chen, Samuel M. Rubinstein, Neeta K. Venepalli, Benjamin F. Tillman, Andrew J. Cowan, Martin W. Schoen, Andrew Malty, J

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Oct 16^th • 12 mins read

J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Sep 26^th • 17 mins read

Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Jan 20^th • 20 mins read

Jonathan H. Cheng, Justin W. Tiulim, Sheng Zhou, Anthony El-Khoueiry and Jorge Nieva

Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials

Oct 18^th • 10 mins read

Navigation

Results for 'Career Progression'

Where Did My Interview Go Wrong?

Mastering the First Impression

Interview Differentiator-Be a Story Teller

12 Interview Techniques to Help Land Your Next Job

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Retention – What Matters Most

10 Ways to Make an Impact on a Phone Interview

Resume Writing and Editing Tips for Pharma Professionals

MSL People Skills: Top 10 Tips for Better Engagement

Promotability: How to Land Your Next Promotion

Positioning Yourself to Become an MSL in 2022

What to do When a Job Offer is Rescinded

Transforming oncology: Five frontiers driving progress in cancer care

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials

Related Topics